Cargando…
Updates in Drug Treatment of Severe Hypertriglyceridemia
PURPOSE OF REVIEW: To provide an insight into the new pharmacological options for the treatment of severe hypertriglyceridemia (sHTG). RECENT FINDINGS: sHTG is difficult to treat. The majority of the traditional pharmacological agents available have limited success in both robustly decreasing trigly...
Autores principales: | Gouni-Berthold, Ioanna, Schwarz, Jonas, Berthold, Heiner K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564803/ https://www.ncbi.nlm.nih.gov/pubmed/37642858 http://dx.doi.org/10.1007/s11883-023-01140-z |
Ejemplares similares
-
PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2022) -
PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014) -
Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2008) -
Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men—A Randomized Trial
por: Berthold, Heiner K., et al.
Publicado: (2014) -
Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans
por: Berthold, Heiner K., et al.
Publicado: (2011)